Ramachandra Kumar Kurumaddali

Active Director Managing Director DIN 02066941

DIN 02066941 First appointment Aug 2001 Primary industry Pharma

Unlock full profile Investments · shareholding · contact details

Current companies 3 active board seats

Past companies 6 historical roles

Total affiliations 9 Since Aug 2001

Shareholding value •••• Premium profile

About Ramachandra Kumar Kurumaddali

Data last updated: 24 August 2026

Ramachandra Kumar Kurumaddali is a Managing Director at Chemo India Formulation Private Limited (since 2015), Director at Senador Laboratories Private Limited (since 2024) and Director at Airpharm India Private Limited (since 2024). The companies operate in Pharma, Food And Beverages and Professional Services. The 2 current companies with reported revenue have a combined latest revenue of ₹136 Cr; the largest is Chemo India Formulation Private Limited at ₹107 Cr (FY 2025). Earlier, Ramachandra Kumar Kurumaddali was a Director at Aizant Drug Research Solutions Private Limited (2005–2008) and Managing Director at Finoso Pharma Private Limited (2009–2015) and 4 more.

DIN 02066941

Primary Designation Managing Director

Industry Pharma

First Appointment 06 Aug 2001

Oldest Company Age 18 yrs

Largest company Chemo India Formulation Private Limited · ₹107 Cr (FY 2025)

Combined revenue ₹136 Cr across 2 companies

Current companies

Company	Designation	Appointment	Founded	Revenue	Status
Chemo India Formulation Private Limited U85100TG2015FTC100239	Managing Director	13 Aug 2015	2015	₹107 Cr (FY 2025)	Active
Senador Laboratories Private Limited U21001TS2023PTC171514	Director	12 Mar 2024	2023	₹29.13 Cr (FY 2024)	Active
Airpharm India Private Limited U52292TS2024FTC191307	Director	25 Nov 2024	2024		Active

Previous companies

Company	Designation	Appointment	Founded	Revenue	Status
Aizant Drug Research Solutions Private Limited U24239TG2005PTC048133	Director	22 Nov 2005	2005	₹193 Cr (FY 2023)	Active
Finoso Pharma Private Limited U24231TG2009PTC064774	Managing Director	18 Aug 2009	2009	₹17.69 Cr (FY 2025)	Active
Kuru Consultants Private Limited U74140AP2001PTC037075	Director	06 Aug 2001	2001		Strike Off
Vivimed Labs (Alathur) Private Limited U24219MH2006PTC165760	Additional Director	07 Oct 2013	2006	₹36.32 Cr (FY 2016)	Amalgamated
Vivozant Biosciences Private Limited U01119TG2008PTC058580	Director	08 Apr 2008	2008		Strike Off
Odyssey Business Solutions Llp AAC-6204	Designated Partner	22 Aug 2014	2014		Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Ramachandra Kumar Kurumaddali

Name	DIN	Company	Designation
Bharat Vasudevan	01666361	Chemo India Formulation Private Limited , Senador Laboratories Private Limited and 1 more	Director
Manuel Ignacio Barro	05134464	Chemo India Formulation Private Limited	Director
Maria Sandra Martin Moran	07128205	Chemo India Formulation Private Limited	Director
Satheesh Rao Ponugoti		Chemo India Formulation Private Limited	Company Secretary
Carlos Romero Camacho Silos	10462233	Senador Laboratories Private Limited , Airpharm India Private Limited	Director
Rafael De Andrade	10462247	Senador Laboratories Private Limited	Additional Director
Rafael Gallego Ollero	10848748	Airpharm India Private Limited	Director

Directorship timeline

Open interactive timeline →

Vivozant Biosciences Private Limited

Chemo India Formulation Private Limited

Odyssey Business Solutions Llp

Senador Laboratories Private Limited

Premium access

Shareholding and investment profile for Ramachandra Kumar Kurumaddali

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

Company-level holdings
Filed share counts
Reported values
Quarterly changes

Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramachandra Kumar Kurumaddali

Which companies is Ramachandra Kumar Kurumaddali currently a director of?

Ramachandra Kumar Kurumaddali currently holds 3 directorships: Chemo India Formulation Private Limited (Managing Director, since 13 Aug 2015, revenue ₹107 Cr (FY 2025)); Senador Laboratories Private Limited (Director, since 12 Mar 2024, revenue ₹29.13 Cr (FY 2024)); Airpharm India Private Limited (Director, since 25 Nov 2024).

When was Ramachandra Kumar Kurumaddali first appointed as a director?

Ramachandra Kumar Kurumaddali was first appointed on 06 Aug 2001 as Director at Kuru Consultants Private Limited. The most recent appointment on record is 25 Nov 2024 at Airpharm India Private Limited.

What is the combined revenue of the companies Ramachandra Kumar Kurumaddali is a director of?

The 2 current companies of Ramachandra Kumar Kurumaddali that report revenue have a combined latest revenue of ₹136 Cr: Chemo India Formulation Private Limited ₹107 Cr (FY 2025); Senador Laboratories Private Limited ₹29.13 Cr (FY 2024).

Which companies was Ramachandra Kumar Kurumaddali previously associated with?

Ramachandra Kumar Kurumaddali held 6 earlier board appointments: Aizant Drug Research Solutions Private Limited (Director, 22 Nov 2005 to 31 Dec 2008); Finoso Pharma Private Limited (Managing Director, 18 Aug 2009 to 02 Feb 2015); Kuru Consultants Private Limited (Director, 06 Aug 2001 to 19 Feb 2008); Vivimed Labs (Alathur) Private Limited (Additional Director, 07 Oct 2013 to 31 Oct 2014); Vivozant Biosciences Private Limited (Director, from 08 Apr 2008); and 1 more.

Who are the other directors of Ramachandra Kumar Kurumaddali's companies?

The current boards of Ramachandra Kumar Kurumaddali's companies include Bharat Vasudevan (Chemo India Formulation Private Limited), Manuel Ignacio Barro (Chemo India Formulation Private Limited), Maria Sandra Martin Moran (Chemo India Formulation Private Limited), Satheesh Rao Ponugoti (Chemo India Formulation Private Limited), Carlos Romero Camacho Silos (Senador Laboratories Private Limited), Rafael De Andrade (Senador Laboratories Private Limited), among others.